[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![MarketPulse360 Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1517444811296587777.png) Market Pulse 360° [@MarketPulse360](/creator/twitter/MarketPulse360) on x XX followers
Created: 2025-07-18 17:24:56 UTC

BiomX's Phase 2b Trial Begins, Analyst Reiterates $XX Target $PHGE



➡️ BiomX initiated patient dosing in Phase 2b trial for BX004, targeting lung infections in cystic fibrosis patients.

➡️ H.C. Wainwright reaffirmed a Buy rating and $XX price target for BiomX, citing confidence in its dual-asset approach.

➡️ Phase 1b/2a trial of BX004 showed XXXX% of patients completely cleared chronic Pseudomonas aeruginosa infections.

➡️ The Phase 2b study will evaluate approximately XX patients over X weeks, with topline results expected Q1 2026.

➡️ BiomX's programs address unmet needs in diabetic foot osteomyelitis and cystic fibrosis, bolstered by military validation.
 

#NYSE

-- 
Paid Ad via #WallStWire: This account is operated by Wall Street Wire. BiomX or a related party has paid Wall Street Wire for ongoing promotional services. Full disclosures: Our content is not financial advice.

![](https://pbs.twimg.com/card_img/1946258904490328064/vfqVqDdT?format=jpg&name=800x419)

XX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1946259910141804881/c:line.svg)

**Related Topics**
[hc](/topic/hc)
[$phge](/topic/$phge)
[pulse](/topic/pulse)

[Post Link](https://x.com/MarketPulse360/status/1946259910141804881)